RT Journal Article
SR Electronic
T1 Rasch Validation of the Revised Body Awareness Rating Questionnaire (BARQ-R) in Adults with Musculoskeletal Pain, Adults with Spinal Cord Injury, and Community-Dwelling Adults in the US
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.19.22274054
DO 10.1101/2022.04.19.22274054
A1 Carpentier, Sydney
A1 Deng, Wei
A1 Blackwood, Jena
A1 Van de Winckel, Ann
YR 2022
UL http://medrxiv.org/content/early/2022/04/21/2022.04.19.22274054.abstract
AB Background To establish Rasch validation of the Revised Body Awareness Rating Questionnaire (BARQ-R) in adults with musculoskeletal pain, community-dwelling adults without pain, and adults with spinal cord injury (SCI) who have neuropathic pain.Materials and Method The BARQ-R has 12 items with scores ranging from 0 (completely disagree) to 3 (completely agree). Through Rasch analysis, we evaluated unidimensionality through item and person fit, targeting of the population, person separation reliability (PSR), local item dependence (LID), and principal components analysis of residuals (PCAR).Results The BARQ-R in adults with musculoskeletal pain (n=152; average age = 52.26±16.13 years) showed good targeting (person mean location: -0.36±0.88 logits), minimal floor effect (0.01%), and no ceiling effect (0.00%) and had good reliability (PSR=0.75). The BARQ-R in community-dwelling adults (n=471; average age = 49.63±17.57 years) had a person mean location of -0.62±1.09 logits, minimal floor (2.63%), and minimal ceiling effect (0.43%) after rescoring 2 items and deleting 3 items and had good reliability (PSR=0.74). The BARQ-R in adults with SCI-related neuropathic pain (n=44; average age = 55.45±13.47 years) showed good targeting after rescoring 7 items (person mean location: -0.33±0.71 logits), no floor effect (0.00%) or ceiling effect (0.00%) but had poor reliability (PSR=0.65).Conclusions The BARQ-R shows sufficient fit to be used in clinical settings for group decision-making for both adults with musculoskeletal pain and community-dwelling adults. However, in adults with SCI-related neuropathic pain, preliminary Rasch analysis of the BARQ-R showed low reliability and therefore the BARQ-R is not recommended for clinical use in that population. Validation in larger groups of adults with SCI as well as more diverse samples are needed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported in this publication was supported by the AIRP2-IND-30: Academic Investment Research Program (AIRP) - University of Minnesota School of Medicine and by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR002494. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study adhered to the principles of the most recent Declaration of Helsinki (2013) and received approval from the Institutional Review Board of the University of Minnesota (IRB#s 00008476; 00011997; 00005656; 00005849).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.BARQBody Awareness Rating QuestionnaireBARQ-RRevised Body Awareness Rating QuestionnairecMDCconditional Minimally Detectable ChangeNPMPNorwegian Psychomotor PhysiotherapyLIDLocal item dependencePSRPersonal Separation ReliabilityRULERRasch Reporting Guideline for Rehabilitation ResearchRUMM2030Rasch Unidimensional Measurement ModelSCISpinal Cord InjuryUSUnited States